Extracellular DNA-associated inflammation in colorectal cancer metastasis: A testable TLR9-NF-κB-SPHK1/S1P framework and translational research agenda

Colorectal cancer (CRC) metastasis, particularly liver metastasis, remains a major cause of treatment failure.Extracellular DNA (eDNA) released from neutrophil extracellular traps, damaged mitochondria, dying tumor cells, and microorganisms can accumulate in the tumor microenvironment, circulation, and liver pre-metastatic niche.This review evaluates whether eDNA sensing may connect chronic inflammation to metastatic progression through a proposed Toll-like receptor 9 (TLR9)-nuclear factor-κBsphingosine kinase 1/sphingosine-1-phosphate framework.TLR9 is considered a candidate endosomal sensor rather than an established initiating node; cyclic GMP-AMP synthase-stimulator of interferon genes and coiled-coil domain-containing protein 25 may cooperate with or substitute for TLR9 according to ligand localization, cellular compartment, and exposure context.Nuclear factor-κB and sphingosine kinase 1/sphingosine-1-phosphate could provide transcriptional and lipid-metabolic links to invasive plasticity, myeloid immunosuppression, vascular remodeling, and therapy resistance.However, no single CRC study has demonstrated the complete cascade from a defined eDNA ligand to metastatic outgrowth using cell-specific perturbation and rescue.The current evidence is further limited by heterogeneous ligand preparation, substantial extrapolation from non-CRC models, and a lack of prospective clinical validation.We therefore present this pathway as a falsifiable research framework and outline priorities for CRC-specific organoid, orthotopic, conditional-knockout, spatial multi-omic, and longitudinal clinical studies.A multidimensional eDNA-axis signature is discussed only as an illustrative future biomarker-development framework, not as a validated score for patient management.This synthesis may help define experiments and biomarker studies needed to determine when eDNA sensing is pro-metastatic, immunostimulatory, or therapeutically actionable in CRC.

Authors

Institutions

Publication Details

Journal
World Journal of Translational Medicine
Published
2026-11-13
DOI
https://doi.org/10.5528/wjtm.124499
Primary Topic
Immune Response and Inflammation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Extracellular DNA-associated inflammation in colorectal cancer metastasis: A testable TLR9-NF-κB-SPHK1/S1P framework and translational research agenda

Yu-hui Shang, Yandong Miao, Kai-Zhen Xu, Wen-Jian Hu et al.
2 links
World Journal of Translational Medicine
Immune Response and Inflammation
article

Extracellular DNA-associated inflammation in colorectal cancer metastasis: A testable TLR9-NF-κB-SPHK1/S1P framework and translational research agenda

Yu-hui Shang, Yandong Miao, Kai-Zhen Xu, Wen-Jian Hu, Jiu-Ning Huang, Shuang Han
article en

Abstract

Colorectal cancer (CRC) metastasis, particularly liver metastasis, remains a major cause of treatment failure.Extracellular DNA (eDNA) released from neutrophil extracellular traps, damaged mitochondria, dying tumor cells, and microorganisms can accumulate in the tumor microenvironment, circulation, and liver pre-metastatic niche.This review evaluates whether eDNA sensing may connect chronic inflammation to metastatic progression through a proposed Toll-like receptor 9 (TLR9)-nuclear factor-κBsphingosine kinase 1/sphingosine-1-phosphate framework.TLR9 is considered a candidate endosomal sensor rather than an established initiating node; cyclic GMP-AMP synthase-stimulator of interferon genes and coiled-coil domain-containing protein 25 may cooperate with or substitute for TLR9 according to ligand localization, cellular compartment, and exposure context.Nuclear factor-κB and sphingosine kinase 1/sphingosine-1-phosphate could provide transcriptional and lipid-metabolic links to invasive plasticity, myeloid immunosuppression, vascular remodeling, and therapy resistance.However, no single CRC study has demonstrated the complete cascade from a defined eDNA ligand to metastatic outgrowth using cell-specific perturbation and rescue.The current evidence is further limited by heterogeneous ligand preparation, substantial extrapolation from non-CRC models, and a lack of prospective clinical validation.We therefore present this pathway as a falsifiable research framework and outline priorities for CRC-specific organoid, orthotopic, conditional-knockout, spatial multi-omic, and longitudinal clinical studies.A multidimensional eDNA-axis signature is discussed only as an illustrative future biomarker-development framework, not as a validated score for patient management.This synthesis may help define experiments and biomarker studies needed to determine when eDNA sensing is pro-metastatic, immunostimulatory, or therapeutically actionable in CRC.

World Journal of Translational Medicine
Shandong University of Aeronautics (CN), Shandong First Medical University (CN)
Binzhou Medical University, FP7 Coordination of Research Activities
Good health and well-being
Immune Response and Inflammation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon